|
MIRM | Mirum Pharmaceuticals, Inc. |
|
|
MIRM | Mirum Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.07 |
| Leverage | 64.85% |
| Market Cap | $ 3.4B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -58.3m |
| Margin | -13.58% |
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.